share_log

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Levy Oded

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities

Cardio Diagnostics | 4：持股變動聲明
美股sec公告 ·  04/09 03:03
牛牛AI助理已提取核心訊息
On March 31, 2024, Levy Oded, associated with Cardio Diagnostics Holdings Inc. [CDIO], completed a purchase transaction of the company's common stock. A total of 8,803 shares were acquired at a price of $1.42 per share. Following this transaction, Levy Oded directly holds a total of 71,596 shares in Cardio Diagnostics Holdings. The transaction is classified as an exercise or conversion of derivative security, indicating a potential increase in the executive's investment in the company.
On March 31, 2024, Levy Oded, associated with Cardio Diagnostics Holdings Inc. [CDIO], completed a purchase transaction of the company's common stock. A total of 8,803 shares were acquired at a price of $1.42 per share. Following this transaction, Levy Oded directly holds a total of 71,596 shares in Cardio Diagnostics Holdings. The transaction is classified as an exercise or conversion of derivative security, indicating a potential increase in the executive's investment in the company.
2024年3月31日，與Cardio Diagnostics Holdings Inc. [CDIO] 關聯的利維·奧德完成了對該公司普通股的收購交易。共收購了8,803股股票，價格爲每股1.42美元。在這筆交易之後，Levy Oded直接持有Cardio Diagnostics Holdings總共71,596股股份。該交易被歸類爲衍生證券的行使或轉換，表明該高管對該公司的投資可能增加。
2024年3月31日，與Cardio Diagnostics Holdings Inc. [CDIO] 關聯的利維·奧德完成了對該公司普通股的收購交易。共收購了8,803股股票，價格爲每股1.42美元。在這筆交易之後，Levy Oded直接持有Cardio Diagnostics Holdings總共71,596股股份。該交易被歸類爲衍生證券的行使或轉換，表明該高管對該公司的投資可能增加。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。